{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T22:06:10Z","timestamp":1792706770738,"version":"4.5.0"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T00:00:00Z","timestamp":1637712000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100018955","name":"NIHR Leeds BRC","doi-asserted-by":"publisher","award":["IS-BRC-1215-20015"],"award-info":[{"award-number":["IS-BRC-1215-20015"]}],"id":[{"id":"10.13039\/501100018955","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,8,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objectives<\/jats:title><jats:p>To investigate whether anti-CCP2-positive at-risk individuals with musculoskeletal (MSK) symptoms but without clinical synovitis (CCP2+ at-risk) develop US subclinical synovitis before inflammatory arthritis and if US subclinical synovitis can be predicted.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>First, US scans of CCP2+ at-risk individuals who developed inflammatory arthritis (\u2018progressors\u2019) were reviewed for subclinical synovitis prior to inflammatory arthritis development. Patients in whom the pre-progression US scan was negative but the scan was conducted &amp;gt;6\u2009months before progression were excluded. Subsequently, regression analyses were performed to identify predictors of US synovitis in CCP2+ at-risk individuals without baseline US abnormalities who had one or more longitudinal US scan and a complete dataset.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>US subclinical synovitis was detected in one or more scan in 75 of 97 progressors (77.3%) {median time to inflammatory arthritis development from first evidence of US synovitis 26.5\u2009weeks [interquartile range (IQR) 7\u201360]}, in whom one or more scan was available, excluding those with a negative scan &amp;gt;6\u2009months from inflammatory arthritis development (n\u2009=\u200938). In 220 CCP2+ at-risk individuals with normal baseline US scans, who had one or more longitudinal US scan and a complete dataset, US synovitis was detected in 69\/220 (31.4%) [median time to first developing US synovitis 56.4\u2009weeks (IQR 33.0\u2013112.0)]. In the multivariable analysis, only anti-CCP3 antibodies were predictive for the development of US synovitis [odds ratio 4.75 (95% CI 1.97, 11.46); P\u2009&amp;lt;\u20090.01].<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>In anti-CCP2+ at-risk individuals, a stage of subclinical synovitis usually precedes the development of inflammatory arthritis. Anti-CCP2+\/CCP3+ individuals without clinical or US subclinical synovitis may represent the optimal window of opportunity for intervention to prevent joint disease.<\/jats:p><\/jats:sec>","DOI":"10.1093\/rheumatology\/keab862","type":"journal-article","created":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T20:14:31Z","timestamp":1637266471000},"page":"3192-3200","source":"Crossref","is-referenced-by-count":26,"title":["Ultrasound subclinical synovitis in anti-CCP-positive at-risk individuals with musculoskeletal symptoms: an important and predictable stage in the rheumatoid arthritis continuum"],"prefix":"10.1093","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0867-7051","authenticated-orcid":false,"given":"Andrea","family":"Di Matteo","sequence":"first","affiliation":[{"name":"Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds"},{"name":"National Institute for Health Research, Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust , Leeds, UK"},{"name":"Rheumatology Unit, Department of Clinical and Molecular Sciences, \u2018Carlo Urbani\u2019 Hospital, Polytechnic University of Marche ,Jesi, Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Duquenne","sequence":"additional","affiliation":[{"name":"Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds"},{"name":"National Institute for Health Research, Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust , Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6881-8197","authenticated-orcid":false,"given":"Edoardo","family":"Cipolletta","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Department of Clinical and Molecular Sciences, \u2018Carlo Urbani\u2019 Hospital, Polytechnic University of Marche ,Jesi, Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline L","family":"Nam","sequence":"additional","affiliation":[{"name":"Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds"},{"name":"National Institute for Health Research, Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust , Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1806-7532","authenticated-orcid":false,"given":"Leticia","family":"Garcia-Montoya","sequence":"additional","affiliation":[{"name":"Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds"},{"name":"National Institute for Health Research, Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust , Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J","family":"Wakefield","sequence":"additional","affiliation":[{"name":"Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds"},{"name":"National Institute for Health Research, Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust , Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7919-0948","authenticated-orcid":false,"given":"Michael","family":"Mahler","sequence":"additional","affiliation":[{"name":"Research and Development, Werfen Autoimmunity , San Diego, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7945-6582","authenticated-orcid":false,"given":"Kulveer","family":"Mankia","sequence":"additional","affiliation":[{"name":"Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds"},{"name":"National Institute for Health Research, Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust , Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7429-8482","authenticated-orcid":false,"given":"Paul","family":"Emery","sequence":"additional","affiliation":[{"name":"Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds"},{"name":"National Institute for Health Research, Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust , Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,11,24]]},"reference":[{"key":"2022080318251507900_keab862-B1","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1136\/annrheumdis-2019-216716","article-title":"The earlier, the better or the worse? Towards accurate management of patients with arthralgia at risk for RA","volume":"79","author":"van der Helm-van Mil","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"2022080318251507900_keab862-B2","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1002\/art.38013","article-title":"The preclinical phase of rheumatoid arthritis: what is acknowledged and what needs to be assessed?","volume":"65","author":"van Steenbergen","year":"2013","journal-title":"Arthritis Rheum"},{"key":"2022080318251507900_keab862-B3","doi-asserted-by":"crossref","first-page":"102399","DOI":"10.1016\/j.jaut.2019.102399","article-title":"Prevention and cure: the major unmet needs in the management of rheumatoid arthritis","volume":"110","author":"Mankia","year":"2020","journal-title":"J Autoimmun"},{"key":"2022080318251507900_keab862-B4","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1136\/annrheumdis-2011-200990","article-title":"EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis","volume":"71","author":"Gerlag","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"2022080318251507900_keab862-B5","first-page":"536","article-title":"Imaging in the preclinical phases of rheumatoid arthritis","volume":"38","author":"Zabotti","year":"2020","journal-title":"Clin Exp Rheumatol"},{"key":"2022080318251507900_keab862-B6","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11926-020-00911-w","article-title":"The role of musculoskeletal ultrasound in the rheumatoid arthritis continuum","volume":"22","author":"Di Matteo","year":"2020","journal-title":"Curr Rheumatol Rep"},{"key":"2022080318251507900_keab862-B7","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.berh.2017.10.006","article-title":"Magnetic resonance imaging in individuals at risk of rheumatoid arthritis","volume":"31","author":"Hunt","year":"2017","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"2022080318251507900_keab862-B8","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1136\/annrheumdis-2015-208235","article-title":"Ultrasound findings predict progression to inflammatory arthritis in anti-CCP antibody-positive patients without clinical synovitis","volume":"75","author":"Nam","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2022080318251507900_keab862-B9","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jbspin.2016.05.011","article-title":"Ultrasound can be useful to predict an evolution towards rheumatoid arthritis in patients with inflammatory polyarthralgia without anticitrullinated antibodies","volume":"84","author":"Zufferey","year":"2017","journal-title":"Joint Bone Spine"},{"key":"2022080318251507900_keab862-B10","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/s13075-017-1405-y","article-title":"Absence of ultrasound inflammation in patients presenting with arthralgia rules out the development of arthritis","volume":"19","author":"van der Ven","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"2022080318251507900_keab862-B11","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1136\/annrheumdis-2020-217215","article-title":"Ultrasound erosions in the feet best predict progression to inflammatory arthritis in anti-CCP positive at-risk individuals without clinical synovitis","volume":"79","author":"Di Matteo","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"2022080318251507900_keab862-B12","first-page":"304","article-title":"THU0072 Ultrasound predicts imminent progression to arthritis in anti-CCP positive at-risk individuals","volume":"78","author":"Duquenne","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"2022080318251507900_keab862-B13","doi-asserted-by":"crossref","first-page":"R98","DOI":"10.1186\/ar3028","article-title":"The value of ultrasonography in predicting arthritis in auto-antibody positive arthralgia patients: a prospective cohort study","volume":"12","author":"van de Stadt","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"2022080318251507900_keab862-B14","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/s13075-018-1767-9","article-title":"The value of joint ultrasonography in predicting arthritis in seropositive patients with arthralgia: a prospective cohort study","volume":"20","author":"van Beers-Tas","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"2022080318251507900_keab862-B15","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1136\/annrheumdis-2014-205227","article-title":"Predicting the development of clinical arthritis in anti-CCP positive individuals with non-specific musculoskeletal symptoms: a prospective observational cohort study","volume":"74","author":"Rakieh","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2022080318251507900_keab862-B16","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1136\/annrheumdis-2015-207871","article-title":"Enriching case selection for imminent RA: the use of anti-CCP antibodies in individuals with new non-specific musculoskeletal symptoms \u2013 a cohort study","volume":"75","author":"Nam","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2022080318251507900_keab862-B17","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1136\/ard.2008.105759","article-title":"Arthritis development in patients with arthralgia is strongly associated with anti-citrullinated protein antibody status: a prospective cohort study","volume":"69","author":"Bos","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"2022080318251507900_keab862-B18","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1136\/annrheumdis-2014-205522","article-title":"Characterising arthralgia in the preclinical phase of rheumatoid arthritis using MRI","volume":"74","author":"van Steenbergen","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2022080318251507900_keab862-B19","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum"},{"key":"2022080318251507900_keab862-B20","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1136\/annrheumdis-2015-208103","article-title":"Prevalence of ultrasound synovial inflammatory findings in healthy subjects","volume":"75","author":"Padovano","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2022080318251507900_keab862-B21","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1007\/s11547-019-01002-2","article-title":"Ultrasound imaging in rheumatoid arthritis","volume":"124","author":"Filippucci","year":"2019","journal-title":"Radiol Med"},{"key":"2022080318251507900_keab862-B22","doi-asserted-by":"crossref","first-page":"e000428","DOI":"10.1136\/rmdopen-2016-000428","article-title":"Scoring ultrasound synovitis in rheumatoid arthritis: a EULAR-OMERACT ultrasound taskforce \u2013 part 1: definition and development of a standardised, consensus-based scoring system","volume":"3","author":"D\u2019Agostino","year":"2017","journal-title":"RMD Open"},{"key":"2022080318251507900_keab862-B23","first-page":"2485","article-title":"Musculoskeletal ultrasound including definitions for ultrasonographic pathology","volume":"32","author":"Wakefield","year":"2005","journal-title":"J Rheumatol"},{"key":"2022080318251507900_keab862-B24","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.immuni.2017.02.006","article-title":"Immunopathogenesis of rheumatoid arthritis","volume":"46","author":"Firestein","year":"2017","journal-title":"Immunity"},{"key":"2022080318251507900_keab862-B25","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1136\/annrheumdis-2020-eular.2028","article-title":"THU0094 In ACPA positive at-risk individuals without clinical arthritis, is ultrasound sufficiently accurate to predict progression to inflammatory arthritis?","volume":"79","author":"Duquenne","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"2022080318251507900_keab862-B26","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/annrheumdis-2020-eular.2427","article-title":"OP0112 In individuals at risk of inflammatory arthritis, patient reported outcomes deteriorate in the 12 weeks before progression to clinical disease","volume":"79","author":"Duquenne","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"2022080318251507900_keab862-B27","first-page":"916","article-title":"SAT0107 Sequential ultrasound shows a late increase in inflammatory burden in anti-CCP positive patients with non-specific musculoskeletal symptoms just before progression to inflammatory arthritis","volume":"77","author":"Pentony","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"2022080318251507900_keab862-B28","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1136\/annrheumdis-2017-212763","article-title":"Effects of B-cell directed therapy on the preclinical stage of rheumatoid arthritis: the PRAIRI study","volume":"78","author":"Gerlag","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"2022080318251507900_keab862-B29","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1002\/art.41402","article-title":"Third-generation anti-cyclic citrullinated peptide antibodies improve prediction of clinical arthritis in individuals at risk of rheumatoid arthritis","volume":"72","author":"Di Matteo","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"2022080318251507900_keab862-B30","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1002\/art.41471","article-title":"Improving the prediction of rheumatoid arthritis using multiple anti-cyclic citrullinated peptide assays","volume":"72","author":"Demoruelle","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"2022080318251507900_keab862-B31","doi-asserted-by":"crossref","first-page":"3872","DOI":"10.1093\/rheumatology\/keaa774","article-title":"Subclinical synovitis in arthralgia: how often does it result in clinical arthritis? Reflecting on starting points for disease-modifying anti-rheumatic drug treatment","volume":"60","author":"Rogier","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"2022080318251507900_keab862-B32","doi-asserted-by":"crossref","first-page":"752","DOI":"10.3390\/healthcare9060752","article-title":"What is the value of ultrasound in individuals \u2018at-risk\u2019 of rheumatoid arthritis who do not have clinical synovitis?","volume":"9","author":"Di Matteo","year":"2021","journal-title":"Healthcare (Basel)"},{"key":"2022080318251507900_keab862-B33","first-page":"S48","article-title":"Ultrasound in osteoarthritis","volume":"32","author":"Iagnocco","year":"2014","journal-title":"Clin Exp Rheumatol"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keab862\/41743071\/keab862.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/61\/8\/3192\/45226877\/keab862.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/61\/8\/3192\/45226877\/keab862.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,12]],"date-time":"2023-11-12T21:14:02Z","timestamp":1699823642000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/61\/8\/3192\/6438028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,24]]},"references-count":33,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,11,24]]},"published-print":{"date-parts":[[2022,8,3]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keab862","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,8,1]]},"published":{"date-parts":[[2021,11,24]]}}}